Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease

被引：0
|
作者：
Fueller, D. [1 ]
Liu, C. [1 ]
Ko, Y. -A. [1 ]
Alkhoder, A. [1 ]
Desai, S. R. [1 ]
Almuwaqqat, Z. [1 ]
Patel, S. A. [1 ]
Ejaz, K. [1 ]
Kauser, T. [1 ]
Martini, A. [1 ]
Alvi, Z. [1 ]
Mehta, P. K. [1 ]
Sperling, L. S. [1 ]
Quyyumi, A. A. [1 ]
机构：
[1] Emory Clin Cardiovasc Res Inst, Atlanta, GA USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] SEX-DIFFERENCES IN CIRCULATING SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) LEVELS AND ITS IMPACT ON THE PROGNOSTIC SIGNIFICANCE OF SUPAR AMONG PATIENTS WITH CORONARY ARTERY DISEASE
    Mehta, Anurag
    Liu, Chang
    Dhindsa, Devinder
    Ko, Yi-An
    Kim, Jeong Hwan
    Sandesara, Pratik
    Tahhan, Ayman Samman
    Topel, Matthew
    Kelli, Heval Mohamed
    Moazzami, Kasra
    Bakhtadze, Beka
    Alkhoder, Ayman
    Martin, Samir
    Sperling, Laurence S.
    Reiser, Jochen
    Hayek, Salim
    Quyyumi, Arshed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 171 - 171
  • [22] Soluble urokinase plasminogen activator receptor (suPAR) for the prediction of ventilator-associated pneumonia (VAP)
    van Oort, Pouline M. P.
    Bos, Lieuwe D.
    Povoa, Pedro
    Ramirez, Paula
    Torres, Antonio
    Artigas, Antonio
    Schultz, Marcus J.
    Martin-Loeches, Ignacio
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [23] Soluble urokinase plasminogen activator receptor suPAR as a marker for inflammation in pediatric inflammatory bowel disease
    Kolho, Kaija-Leena
    Valtonen, Elsa
    Rintamaki, Hanne
    Savilahti, Erkki
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (8-9) : 951 - 955
  • [24] Assessment of Serum Levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Patients with Periodontitis and Atheroscletotic Cardiovascular Disease
    Hamad, Safa Ali
    Mahmood, Maha Shukri
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (02): : 719 - 723
  • [25] Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in psoriasis patients and correlation with disease severity
    Kurtipek, Gulcan Saylam
    Kesli, Recep
    Akyurek, Fatma Tuncez
    Akyuret, Fikret
    Terzi, Yuksel
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2015, 24 (04): : 73 - 75
  • [26] Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia
    Toldi, Gergely
    Biro, Edina
    Szalay, Balazs
    Stenczer, Balazs
    Molvarec, Attila
    Rigo, Janos, Jr.
    Vasarhelyi, Barna
    Beko, Gabriella
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (11) : 1873 - 1876
  • [27] Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children
    Weidemann, Darcy K.
    Abraham, Alison G.
    Roem, Jennifer L.
    Furth, Susan L.
    Warady, Bradley A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (02) : 194 - 202
  • [28] The cardioprotective potential of soluble urokinase Plasminogen Activator Receptor (suPAR) in myocardial ischemia
    Pirker, T.
    Keys, T.
    Pham, T.
    Montecillo, J.
    Byers, M.
    Adamson, P.
    Richards, A. M.
    Pemberton, C.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [29] Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in ankylosing spondylitis
    Toldi, Gergely
    Szalay, Balazs
    Beko, Gabriella
    Kovacs, Laszlo
    Vasarhelyi, Barna
    Balog, Attila
    JOINT BONE SPINE, 2013, 80 (01) : 96 - 98
  • [30] Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
    Rasmussen, Line Jee Hartmann
    Petersen, Jens Emil Vang
    Eugen-Olsen, Jesper
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345